subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Safety Issues


subject: CHEBI:4027

subject_name: Cyclophosphamide

tested_intervention: unsure


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin


subject: UNII:KG6VO684Z6

object_name: Effects of chemotherapy


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UNII:AG9MHG098Z


subject: UMLS:C3274626

subject_name: Lactobacillus brevis CD2 Lozenge

object_name: Neck Carcinoma

tested_intervention: yes


subject: UMLS:C3274626

object_name: head and neck neoplasm


subject: UMLS:C3274626

object_name: head and neck cancer


subject: UMLS:C3274626

object_name: Oral Complication of Radiation Therapy


subject: UMLS:C3274626

object_name: Weight Fluctuation


subject: UMLS:C3274626

object_name: Weight Change


subject: CHEBI:63610

subject_name: Misoprostol

object_name: induced labor (history)


subject: CHEBI:63610

object_name: Onset of labor induced (finding)


subject: CHEBI:606564

subject_name: prostaglandin E2(1-)


subject: UMLS:C3813211

subject_name: Prostaglandin E2


subject: CHEBI:15551

subject_name: Dinoprostone


subject: UMLS:C2347432

object_name: head and neck squamous cell carcinoma


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: T-Cell Lymphoma


subject: UNII:3A189DH42V

object_name: Lymphoma, Extranodal NK-T-Cell


subject: PUBCHEM.COMPOUND:56841998

subject_name: Epoch


subject: PUBCHEM.COMPOUND:56841998


subject: PUBCHEM.COMPOUND:126481870

subject_name: valemetostat

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:126481870

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:126481870

object_name: breast cancer


subject: UNII:60RD0234VE

subject_name: Valemetostat


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: CHEBI:63925

subject_name: PhXa 85

object_name: Disorder of intraocular pressure


subject: CHEBI:63925

object_name: Intraocular Pressure


subject: CHEBI:3757

subject_name: Clonidine

object_name: osteoarthritis, knee


subject: CHEBI:48140

subject_name: silicone macromolecule

object_name: keloid


subject: CHEBI:48140

object_name: Cicatrix, Hypertrophic


subject: UMLS:C5700169

subject_name: Silicone-containing product


subject: UMLS:C5700169


subject: MESH:D012828

subject_name: Silicones


subject: MESH:D012828


subject: CHEBI:61459

subject_name: silicone polymer


subject: CHEBI:61459


subject: UMLS:C3896901

object_name: sarcoma


subject: UMLS:C3896901

object_name: soft tissue sarcoma


subject: UNII:0T8392U5N1

subject_name: GLUCOSE OXIDASE

object_name: Xerostomia


subject: CHEBI:17234

subject_name: D-glucose


subject: UMLS:C0017735

subject_name: glucose oxidase


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin


subject: PR:000009978

subject_name: lactotransferrin


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: CHEBI:83094

subject_name: (R)-lipoamide


subject: UNII:968JKA7T33

subject_name: LYSOZYME


subject: PUBCHEM.COMPOUND:91976556

subject_name: Muramidase


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol


subject: CHEBI:17151


subject: UMLS:C0070324

subject_name: peppermint preparation


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:28939

object_name: heart valve disorder


subject: CHEBI:28939

object_name: Postoperative Complications


subject: CHEBI:28939

object_name: Surgery--Complications


subject: CHEBI:5298

subject_name: Genipin

object_name: Inflammation of superficial digital flexor tendon of equine limb


subject: UMLS:C1505595

object_name: neoplasm


subject: UMLS:C1505595

object_name: cancer


subject: UMLS:C0591202

subject_name: brufen retard

object_name: Post-Operative Pain


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: focal segmental glomerulosclerosis


subject: CHEBI:32016

object_name: proteinuria


subject: CHEBI:32016

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:32016

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:32016

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:32016

object_name: kidney failure


subject: CHEBI:32016

object_name: nephrotic syndrome


subject: CHEBI:32016

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:3048

subject_name: Benzatropine

object_name: Agitation, CTCAE 3.0


subject: CHEBI:3048

object_name: Agitation


subject: CHEBI:3048

object_name: Agitation, CTCAE 5.0


subject: CHEBI:52993

subject_name: Lormetazepam


subject: CHEBI:52993


subject: CHEBI:52993


subject: CHEBI:6539

subject_name: Lorazepam


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:8707

subject_name: Quetiapine


subject: CHEBI:8707


subject: CHEBI:64312

subject_name: Memantine

object_name: fibromyalgia


subject: CHEBI:49662

subject_name: Indomethacin

object_name: post term pregnancy


subject: CHEBI:2955

subject_name: Azithromycin

object_name: pertussis


subject: CHEBI:2955

object_name: Whooping cough


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Tumor Mass


subject: UMLS:C1440044

subject_name: A,B

object_name: Poisoning by scorpion sting


subject: CHEBI:50202

subject_name: naringenin

object_name: hepatitis C


subject: UMLS:C5557572

subject_name: Pam3Cys-GDPKHPKSF XS15

object_name: brain glioblastoma


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: trigeminal neuralgia


subject: CHEBI:6413

subject_name: Letrozole

object_name: brain neoplasm


subject: UMLS:C4278474

object_name: Behcet disease


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Drug Interactions


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:8382

subject_name: Prednisone

object_name: inflammatory disease


subject: CHEBI:8382

object_name: Autoimmune reaction


subject: MESH:D005232

subject_name: Fatty Acids, Volatile

object_name: poisoning


subject: MESH:D005232

object_name: Radiation Sickness


subject: UNII:4X4HLN92OT

subject_name: Tribulus terrestris

object_name: Sexual Functions and Problems in the Adult


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:21634109

object_name: amyotrophic lateral sclerosis


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: Frontal lobe dysfunction


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib

object_name: Castration-Sensitive Prostate Carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:6456

subject_name: Lidocaine

object_name: osteoarthritis


subject: CHEBI:6709

subject_name: Meclizine

object_name: Adverse drug response


subject: UMLS:C0740483

subject_name: Kwells


subject: CHEBI:91541


subject: GTOPDB:8944

subject_name: emactuzumab

object_name: tenosynovial giant cell tumor


subject: GTOPDB:8944

object_name: testicular germ cell tumor


subject: GTOPDB:8944

object_name: tenosynovial giant cell tumor, diffuse type


subject: UNII:6FY6EI1X8R


subject: UNII:6FY6EI1X8R


subject: UNII:6FY6EI1X8R


subject: UMLS:C4078926


subject: UMLS:C4078926


subject: UMLS:C4078926


subject: CHEBI:78825

subject_name: Avutometinib

object_name: ovarian cancer


subject: CHEBI:78825

object_name: ovarian neoplasm


subject: CHEBI:78825

object_name: ovarian carcinoma


subject: UMLS:C2980817

subject_name: Morinda citrifolia fruit extract

object_name: Neoplasm Metastasis


subject: UMLS:C2980817

object_name: neoplasm


subject: CHEBI:57858

subject_name: atropinium

object_name: no feeling or sensation of skin


subject: CHEBI:57858

object_name: Sensory Loss


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:92712


subject: CHEBI:91541


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UMLS:C1161352


subject: UMLS:C4724859

subject_name: Geptanolimab

object_name: cervical cancer


subject: UMLS:C4724859

object_name: cervical carcinoma


subject: UMLS:C1541530

object_name: sarcoma


subject: UMLS:C1541530

object_name: soft tissue sarcoma


subject: UMLS:C1541530

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Safety Issues


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: Low back pain


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: PUBCHEM.COMPOUND:91820686

subject_name: janagliflozin

object_name: type 2 diabetes mellitus


subject: UNII:WK4RT85HCA

subject_name: Janagliflozin


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Fatty Liver


subject: CHEBI:6801

subject_name: Metformin

object_name: hypogonadism


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:21873174

object_name: obesity


subject: PUBCHEM.COMPOUND:21873174

object_name: Obesity, CTCAE


subject: UMLS:C0006055

subject_name: Botulinum Toxins

object_name: plantar fasciitis


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: rectum adenocarcinoma


subject: CHEBI:85994

object_name: rectal carcinoma


subject: CHEBI:85994

object_name: rectal cancer


subject: CHEBI:85994

object_name: Childhood Rectal Carcinoma


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: coronary aneurysm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Non-Cancer Diagnosis


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:71417

subject_name: Procarbazine


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: childhood medulloblastoma


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: sciatica


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: GTOPDB:13796

subject_name: serplulimab

object_name: biliary tract cancer


subject: GTOPDB:13796

object_name: pancreatic neoplasm


subject: GTOPDB:13796

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:13796

object_name: malignant pancreatic neoplasm


subject: GTOPDB:13796

object_name: Extrapulmonary Small Cell Carcinoma


subject: GTOPDB:13796

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C4745029


subject: UMLS:C4745029


subject: UMLS:C4745029


subject: UMLS:C4745029


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib


subject: UNII:B2K5L1L8S9

object_name: esophageal squamous cell carcinoma


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Bone injury


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: CHEBI:9943

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UMLS:C2918046

subject_name: Venlafaxine Hydrochloride ER


subject: UMLS:C2918046


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: colorectal cancer


subject: CHEBI:32016

object_name: colorectal carcinoma


subject: CHEBI:32016

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Medication interaction potentiation


subject: CHEBI:63660


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:9150


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine


subject: GTOPDB:4985

object_name: Advanced breast cancer


subject: GTOPDB:4985

object_name: Advanced lung cancer


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UNII:06CA9QMG6Z

object_name: treatment resistant depression


subject: UNII:06CA9QMG6Z


subject: UMLS:C5433654


subject: UMLS:C5433654


subject: MESH:D010919

subject_name: Placebos


subject: MESH:D010919


subject: UNII:0A6746FWDL

subject_name: benidipine hydrochloride

object_name: Chronic coronary syndrome


subject: UNII:0A6746FWDL

object_name: Angina pectoris


subject: UNII:0A6746FWDL

object_name: hypertension


subject: UNII:0A6746FWDL

object_name: Hypertension, CTCAE


subject: CHEBI:135806

subject_name: benidipine


subject: CHEBI:135806


subject: CHEBI:135806


subject: CHEBI:135806


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: Childhood Neuroblastoma


subject: CHEBI:28793

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:439262

subject_name: Beta-Glucan


subject: PUBCHEM.COMPOUND:439262


subject: CHEBI:229389

subject_name: nerylacetone

object_name: Non-steroidal anti-inflammatory drug adverse reaction


subject: CHEBI:31649

subject_name: teprenone


subject: CHEMBL.COMPOUND:CHEMBL5314356

subject_name: TEPRENONE


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: hormone-resistant prostate carcinoma


subject: UNII:DPT0O3T46P

object_name: Prostate cancer recurrent


subject: MESH:C551013

subject_name: Grazax

object_name: Allergic rhinitis caused by grass pollen


subject: PUBCHEM.COMPOUND:62957

subject_name: Oviol

object_name: Uses contraception (finding)


subject: UMLS:C0678132

subject_name: Marvelon


subject: CHEBI:50858

subject_name: corticosteroid

object_name: EXCESS LMW-DNA


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Atrophic


subject: CHEBI:233364

subject_name: Bryostatin

object_name: Melanoma recurrent


subject: CHEBI:233364

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:233364

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:233364

object_name: metastatic melanoma


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: fibromatosis


subject: PUBCHEM.COMPOUND:131769963

object_name: desmoid tumor


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Cannabis use disorder


subject: CHEBI:42797

object_name: bipolar I disorder


subject: CHEBI:42797

object_name: Substance Use Disorders


subject: CHEBI:42797

object_name: bipolar II disorder


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: Mycobacterium avium complex disease


subject: CHEBI:41001


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: PUBCHEM.COMPOUND:251912


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C2698319


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: PR:000002994


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C4053587

subject_name: TA-CIN

object_name: Low Grade Squamous Intraepithelial Neoplasia


subject: UMLS:C5446601

subject_name: pNGVL4a-CRT-E6E7L2 DNA Vaccine


subject: UNII:YB18NF020M

subject_name: Satralizumab

object_name: Myasthenia Gravis, Generalized


subject: UMLS:C0051427

subject_name: Demser

object_name: Childhood Breast Carcinoma


subject: UMLS:C0051427

object_name: breast carcinoma


subject: UMLS:C0051427

object_name: breast cancer


subject: UMLS:C0051427

object_name: Carcinoma breast stage IV


subject: UMLS:C0051427

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: PUBCHEM.COMPOUND:124037376

object_name: Post-Operative Pain


subject: CHEMBL.COMPOUND:CHEMBL4297775


subject: UMLS:C3712782


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Frailty Syndrome


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: kidney disorder


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:16129616

subject_name: Calcitonin

object_name: Fractured forearm bone


subject: CHEBI:184662


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Metastatic Uveal Melanoma


subject: CHEBI:45716

object_name: Stage IV Uveal Melanoma AJCC v7


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: pemphigus vulgaris


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Craniofacial Pain


subject: CHEBI:3215

object_name: Sphenopalatine Neuralgia


subject: CHEBI:3215

object_name: trigeminal autonomic cephalalgia


subject: CHEBI:3215

object_name: paroxysmal Hemicrania


subject: CHEBI:3215

object_name: cluster headache syndrome


subject: CHEBI:16344

subject_name: Glycocyamine

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: cutaneous leishmaniasis


subject: CHEBI:6909

subject_name: Metronidazole


subject: UNII:2P3VWU3H10

subject_name: ACTIVATED CHARCOAL

object_name: Hemorrhagic disorder due to circulating anticoagulants


subject: CHEBI:27594

subject_name: Graphite


subject: CHEBI:82339

subject_name: Merphalan

object_name: inherited hemoglobinopathy


subject: CHEBI:82339

object_name: hemoglobinopathy


subject: CHEBI:82339

object_name: immunodeficiency disease


subject: CHEBI:82339

object_name: thalassemia


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: photosensitive epilepsy


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:124965

subject_name: Opaganib

object_name: liver carcinoma


subject: UMLS:C2933332


subject: UMLS:C2933331

subject_name: Yeliva


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: asthma


subject: UMLS:C0281549

subject_name: Zenapax


subject: UMLS:C1832064

subject_name: Anti-Flt-1 Ribozyme

object_name: renal carcinoma


subject: UMLS:C1832064

object_name: kidney neoplasm


subject: UMLS:C1832064

object_name: kidney cancer


subject: UMLS:C5238055

subject_name: Tengonermin

object_name: OVARIAN CANCER METASTATIC RECURRENT


subject: UMLS:C1143119

subject_name: Zafiride


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UMLS:C1562036

subject_name: Calcineurin inhibitor

object_name: acute graft versus host disease


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: nephrotic syndrome of childhood - steroid sensitive


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:80139

subject_name: Neuromedin B

object_name: Malignant tumor of digestive organ


subject: CHEBI:80139

object_name: malignant urinary system neoplasm


subject: CHEBI:80139

object_name: Malignant neoplasm of female genital organs


subject: CHEBI:80139

object_name: male reproductive organ cancer


subject: CHEBI:7514

subject_name: Neostigmine


subject: CHEBI:7514


subject: CHEBI:7514


subject: CHEBI:7514


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: PUBCHEM.COMPOUND:74030550


subject: PUBCHEM.COMPOUND:74030550


subject: UNII:T0N62K2M2Y

object_name: rheumatoid arthritis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Hypotension during surgery


subject: CHEBI:177605

subject_name: Samidorphan

object_name: schizophrenia


subject: UNII:939U7C91AI

subject_name: Solriamfetol

object_name: recurrent hypersomnia


subject: UNII:939U7C91AI

object_name: idiopathic hypersomnia


subject: UNII:DW94IAT0LS

object_name: Advanced Gastric Adenocarcinoma


subject: PUBCHEM.COMPOUND:23083982

subject_name: Elvitegravir

object_name: HIV-1 infection


subject: UMLS:C0042210

subject_name: Vaccines

object_name: cancer


subject: UMLS:C0042210

object_name: Tumor Mass


subject: UMLS:C0042210

object_name: Childhood Solid Neoplasm


subject: UMLS:C0042210

object_name: Solid Neoplasm


subject: UMLS:C0042210

object_name: Embolism, Tumor


subject: UMLS:C0042210

object_name: Neoplasm Metastasis


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C2744441

object_name: melanoma


subject: UMLS:C2744441

object_name: glioblastoma


subject: UMLS:C2744441

object_name: Brain Stem Glioblastoma


subject: UMLS:C2744441

object_name: glioma susceptibility 1


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: UMLS:C3658202

subject_name: Androxal

object_name: Drug Interactions


subject: CHEBI:74538

subject_name: Leu-Gly-Gly

object_name: infant; premature, light-for-dates


subject: CHEBI:74538

object_name: Breastfeeding (mother)


subject: UMLS:C0721277

subject_name: LGG brand of Dyphylline/Guaifenesin


subject: UMLS:C0721277


subject: UMLS:C1832078

subject_name: LGG Lactobacillus rhamnosus GG


subject: UMLS:C1832078


subject: CHEBI:3423

subject_name: Carmustine

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: CHEBI:3423

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: UNII:01KC87F8FE


subject: UNII:01KC87F8FE


subject: UMLS:C4722366


subject: UMLS:C4722366

object_name: neoplasm


subject: UMLS:C5854525

subject_name: Anti-CD3/CD38 Bispecific Monoclonal Antibody IGM-2644

object_name: plasma cell myeloma


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: female reproductive system neoplasm


subject: CHEBI:175901

object_name: Pelvic Neoplasms


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UNII:G8RGG88B68

object_name: metastatic gastrointestinal carcinoid tumor


subject: UNII:G8RGG88B68

object_name: Regional Digestive System Neuroendocrine Tumor G1


subject: UNII:G8RGG88B68

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: epithelioid hemangioendothelioma


subject: CHEBI:231005


subject: CHEBI:231005

object_name: Adult Epithelioid Hemangioendothelioma


subject: CHEBI:231005

object_name: pediatric angiosarcoma


subject: CHEBI:231005

object_name: angiosarcoma


subject: CHEBI:231005

object_name: Adult Angiosarcoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: MESH:C572111

subject_name: high-amylose maize type 2 resistant starch, maize

object_name: colorectal cancer


subject: MESH:C572111

object_name: colorectal carcinoma


subject: MESH:C572111

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:181906

subject_name: Polydextrose


subject: CHEBI:181906


subject: CHEBI:181906


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: CHEBI:76842

object_name: liver carcinoma


subject: CHEBI:76842

object_name: Metastatic hepatocellular carcinoma


subject: CHEBI:28001

subject_name: Vancomycin


subject: GTOPDB:9310

subject_name: lirilumab

object_name: non-Hodgkin lymphoma


subject: GTOPDB:9310

object_name: Hodgkin Disease


subject: GTOPDB:9310

object_name: Adult Hodgkin Lymphoma


subject: GTOPDB:9310

object_name: Childhood Hodgkin Lymphoma


subject: UNII:S9XDI9W918

subject_name: LIRILUMAB


subject: UNII:S9XDI9W918


subject: UNII:S9XDI9W918


subject: UNII:S9XDI9W918


subject: UMLS:C3641620


subject: UMLS:C3641620


subject: UMLS:C3641620


subject: UMLS:C3641620


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690


subject: CHEBI:72690


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: acute myeloid leukemia


subject: CHEBI:83766

subject_name: Olaparib

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:83766

object_name: rhabdomyosarcoma


subject: CHEBI:83766

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:83766

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: MESH:C000721547

object_name: type 2 diabetes mellitus


subject: CHEBI:6931

subject_name: Midazolam

object_name: Upper gastrointestinal hemorrhage


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:9130

subject_name: Sevoflurane


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Evidence of liver transplantation


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Morphine adverse reaction


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Complication of hemodialysis


subject: CHEBI:16347

object_name: hyperthyroidism treated or under control


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: Advanced renal cell carcinoma


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C0306016

subject_name: DuoDERM CGF

object_name: Biopsy wound (morphologic abnormality)


subject: UMLS:C0306016

object_name: Surgical wound


subject: CHEBI:7025

subject_name: Mupirocin


subject: CHEBI:7025


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:135576

subject_name: Bunazosin

object_name: hypertension


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: hypertrophic cardiomyopathy


subject: CHEBI:94789

object_name: Hypertrophic cardiomyopathy without obstruction


subject: PUBCHEM.COMPOUND:16119086

object_name: Tourette syndrome


subject: UNII:G3QE979K1X


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: esophageal disorder


subject: UNII:73096E137E


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: lymphoma, non-Hodgkin, familial


subject: PR:000005931


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: vulvar lichen sclerosus


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: Classic Follicular Lymphoma


subject: UNII:LDJ89SS0YG

object_name: Follicular Lymphoma with Unusual Cytological Features


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase


subject: PUBCHEM.COMPOUND:91820602


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394


subject: CHEBI:135117

subject_name: ftivazide

object_name: meningeal tuberculosis


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: CHEBI:38666

subject_name: Tarenflurbil

object_name: prostate carcinoma


subject: CHEBI:38666

object_name: prostate cancer


subject: UMLS:C0973783

subject_name: acetazolamide 500 MG Extended Release Oral Capsule

object_name: Post-Operative Pain


subject: UMLS:C0973783

object_name: Pain, Referred


subject: RXCUI:1656336

subject_name: sacubitril / valsartan Oral Product

object_name: type 2 diabetes mellitus


subject: RXCUI:1656336

object_name: Diabetes


subject: RXCUI:1656336

object_name: diabetes mellitus


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: gallbladder adenocarcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C4045524

object_name: pancreatic adenocarcinoma


subject: UMLS:C4045524

object_name: rectum adenocarcinoma


subject: UMLS:C4045524

object_name: colon adenocarcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UMLS:C0534628

subject_name: Endostatins

object_name: liver carcinoma


subject: CHEBI:135041

subject_name: phenbenzamine

object_name: Chronic pediatric feeding disorder


subject: CHEBI:135041

object_name: Avoidant Restrictive Food Intake Disorder


subject: CHEBI:4046

subject_name: Cyproheptadine


subject: CHEBI:4046


subject: UMLS:C3272509

object_name: Childhood Breast Carcinoma


subject: UMLS:C3272509

object_name: breast carcinoma


subject: UMLS:C3272509

object_name: breast cancer


subject: UMLS:C3272509

object_name: HER2 positive breast carcinoma


subject: UMLS:C4045974

subject_name: Biosimilars

object_name: sickle cell disease


subject: UNII:KUW1QG1ZM3

subject_name: siplizumab


subject: UMLS:C1310928


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: Drug-induced constipation


subject: CHEBI:82975

subject_name: Naloxegol


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: nongerminomatous germ cell tumor


subject: CHEMBL.COMPOUND:CHEMBL2109465

object_name: Crohn disease


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: Carcinoma breast stage IV


subject: CHEBI:90001

subject_name: cystathionine ketimine


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: CHEBI:95346

subject_name: Atovaquone

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:95346

object_name: acute myeloid leukemia


subject: CHEBI:16069

subject_name: Imidazole

object_name: triple-negative breast carcinoma


subject: CHEBI:16069

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:16069


subject: CHEBI:16069


subject: CHEBI:16069


subject: CHEBI:16069

object_name: Early Stage Triple-Negative Breast Carcinoma


subject: CHEBI:16069

object_name: Breast cancer stage II


subject: CHEBI:16069

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:16069

object_name: Breast cancer stage III


subject: CHEBI:16069

object_name: breast neoplasm


subject: CHEBI:39168

subject_name: Imidacloprid


subject: CHEBI:39168


subject: CHEBI:39168

object_name: Childhood Breast Carcinoma


subject: CHEBI:39168

object_name: breast carcinoma


subject: CHEBI:39168

object_name: breast cancer


subject: CHEBI:39168


subject: CHEBI:39168


subject: CHEBI:39168


subject: CHEBI:39168


subject: CHEBI:39168


subject: UMLS:C2932027

object_name: atrial fibrillation


subject: UMLS:C2932027

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C2932027

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: preterm premature rupture of the membranes


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Family history of ischemic heart disease


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: enuresis


subject: PUBCHEM.COMPOUND:27991

object_name: Urinary incontinence of non-organic origin


subject: PUBCHEM.COMPOUND:27991

object_name: Urinary incontinence


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: PUBCHEM.COMPOUND:16051933


subject: PUBCHEM.COMPOUND:16051933


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:5118


subject: CHEBI:5118


subject: UMLS:C5666846

subject_name: HDAC Inhibitor REC-2282

object_name: neurofibromatosis


subject: UMLS:C5666846

object_name: NF2-related schwannomatosis


subject: UMLS:C5666846

object_name: vestibular schwannomatosis


subject: MESH:C000590843

subject_name: simiaowan

object_name: Primary gout


subject: MESH:C000590843

object_name: Gout flare


subject: CHEBI:233364

subject_name: Bryostatin

object_name: AIDS-Related Diffuse Mixed Cell Lymphoma


subject: CHEBI:233364

object_name: AIDS-Related Diffuse Large Cell Lymphoma


subject: CHEBI:233364

object_name: Burkitt lymphoma associated with AIDS


subject: CHEBI:233364


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:88353


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:15765

subject_name: Levodopa

object_name: aphasia


subject: CHEBI:15765

object_name: stroke disorder


subject: CHEBI:15765

object_name: cerebrovascular disorder


subject: MESH:C000716647

object_name: Toxic effect of ethyl alcohol


subject: UMLS:C4082808

subject_name: Advagraf

object_name: Acute rejection of renal transplant


subject: UMLS:C4082808

object_name: Post transplant diabetes mellitus


subject: UMLS:C4082808

object_name: Heart Disease Risk Factors


subject: UMLS:C4082808

object_name: outcomes general quality of life


subject: UMLS:C4082808

object_name: Perceived quality of life


subject: UMLS:C4082808

object_name: Good quality of life


subject: UMLS:C4082808

object_name: Graft failure


subject: UMLS:C4082808

object_name: Infection


subject: UMLS:C4082808

object_name: Infection of musculoskeletal system


subject: UMLS:C4082808

object_name: bone disorder


subject: UMLS:C4082808

object_name: Adverse Event Associated with Death


subject: UMLS:C4082808

object_name: Death (finding)


subject: UMLS:C4082808

object_name: Death


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C0013227

object_name: COPD, severe early onset


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UNII:67RM91WDHQ

subject_name: Onvansertib

object_name: small cell lung carcinoma


subject: CHEBI:16796

subject_name: Melatonin

object_name: opioid use


subject: UMLS:C2827540

subject_name: Menadione Topical Lotion

object_name: Dermatologic Complication


subject: UMLS:C2827540

object_name: Primary malignant neoplasm


subject: UMLS:C2827540

object_name: cancer


subject: UMLS:C2827540

object_name: childhood malignant neoplasm


subject: UMLS:C2827540

object_name: Malignant obstetric neoplasm


subject: UNII:TUK9QB44B0

object_name: Sicca Syndrome


subject: UMLS:C5392518


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Neoplasm of uncertain or unknown behavior of prostate


subject: PUBCHEM.COMPOUND:92043599

object_name: grade III prostatic intraepithelial neoplasia


subject: PUBCHEM.COMPOUND:92043599

object_name: benign neoplasm of prostate


subject: PUBCHEM.COMPOUND:92043599

object_name: carcinoma


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: prostate carcinoma


subject: CHEBI:5790

object_name: prostate cancer


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:38562

object_name: metabolic syndrome X


subject: CHEBI:82339

subject_name: Merphalan

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Neuropathic pain


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: GTOPDB:8221

subject_name: epacadostat

object_name: metastatic colorectal cancer


subject: UNII:2HR315841W


subject: UMLS:C2985191


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: ovarian cancer


subject: CHEBI:47097

object_name: ovarian neoplasm


subject: CHEBI:47097

object_name: ovarian carcinoma


subject: CHEBI:47097

object_name: Stomach cancer


subject: CHEBI:47097

object_name: gastric cancer


subject: UMLS:C2351399

object_name: rheumatoid arthritis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: intracranial hypertension


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:5523

subject_name: Goserelin

object_name: triple-negative breast carcinoma


subject: CHEBI:5523

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:7459

subject_name: Naloxone

object_name: Low back pain


subject: UNII:MQ5GV2WUK4

subject_name: LERAPOLTUREV

object_name: bladder tumor


subject: UNII:MQ5GV2WUK4

object_name: urinary bladder carcinoma


subject: UNII:MQ5GV2WUK4

object_name: urinary bladder cancer


subject: UNII:MQ5GV2WUK4

object_name: childhood bladder carcinoma


subject: UNII:MQ5GV2WUK4

object_name: Childhood Solid Neoplasm


subject: UNII:MQ5GV2WUK4

object_name: Adult Solid Neoplasm


subject: UNII:MQ5GV2WUK4

object_name: Solid Neoplasm


subject: UNII:MQ5GV2WUK4

object_name: superficial urinary bladder carcinoma


subject: CHEBI:134738

subject_name: Laquinimod

object_name: Crohn disease


subject: CHEBI:41423

subject_name: Celecoxib

object_name: skin melanoma


subject: CHEBI:41423

object_name: Cachexia


subject: CHEBI:6931

subject_name: Midazolam

object_name: acute respiratory distress syndrome


subject: UNII:2NDX4B6N8F

subject_name: HA 22

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UMLS:C2346797


subject: UMLS:C5206625

subject_name: Tubulin Inhibitor ALB-109564

object_name: cancer


subject: UMLS:C5206625

object_name: neoplasm


subject: CHEBI:17688

subject_name: Nicotine

object_name: Postoperative ileus


subject: DRUGBANK:DB17601

subject_name: Ixmyelocel-T

object_name: dilated cardiomyopathy


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: myocardial infarction


subject: CHEBI:5801

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:5801

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:5801

object_name: acute coronary syndrome


subject: CHEBI:87631

subject_name: statin

object_name: Malignant neoplasm of female breast


subject: CHEBI:32682

subject_name: L-argininium

object_name: Androgen excess


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:188074

object_name: Angina pectoris


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0699319

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0699319

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0699319

object_name: plasma cell myeloma


subject: DRUGBANK:DB18503

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: DRUGBANK:DB18503

object_name: amyotrophic lateral sclerosis


subject: CHEMBL.COMPOUND:CHEMBL2146146

subject_name: ATROPINE SULFATE

object_name: Mydriasis


subject: CHEMBL.COMPOUND:CHEMBL2146146

object_name: Adverse drug response


subject: CHEMBL.COMPOUND:CHEMBL2146146

object_name: cataract


subject: CHEMBL.COMPOUND:CHEMBL2146146

object_name: Cataract, CTCAE 3.0


subject: CHEMBL.COMPOUND:CHEMBL2146146

object_name: Cataract, CTCAE 5.0


subject: CHEMBL.COMPOUND:CHEMBL2146146

object_name: cataract on exam (physical finding)


subject: UNII:03J5ZE7KA5


subject: UNII:03J5ZE7KA5


subject: UNII:03J5ZE7KA5


subject: UNII:03J5ZE7KA5


subject: UNII:03J5ZE7KA5


subject: UNII:03J5ZE7KA5


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Non-ischaemic dilated cardiomyopathy


subject: PUBCHEM.COMPOUND:72750241

subject_name: Eldecalcitol

object_name: sarcopenia


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: opioid use


subject: UMLS:C0358855

object_name: opioid abuse


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic well-differentiated neuroendocrine tumor


subject: CHEBI:135901

subject_name: lanreotide


subject: UMLS:C0051846

subject_name: angiopeptin


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Hormone-dependent prostate cancer


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: GTOPDB:7385

subject_name: catumaxomab

object_name: urinary bladder carcinoma


subject: GTOPDB:7385

object_name: urinary bladder cancer


subject: GTOPDB:7385

object_name: childhood bladder carcinoma


subject: UNII:M2HPV837HO


subject: UNII:M2HPV837HO


subject: UNII:M2HPV837HO


subject: UMLS:C1831854


subject: UMLS:C1831854


subject: UMLS:C1831854


subject: CHEBI:68584

subject_name: Ezogabine

object_name: herpes zoster


subject: CHEBI:68584

object_name: postherpetic neuralgia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Sclerosis


subject: CHEBI:4026

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:12460

subject_name: Phendimetrazine

object_name: cocaine use disorder


subject: UNII:XSZ53G39H5

subject_name: Brolucizumab

object_name: wet macular degeneration


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: melanoma


subject: UMLS:C0211023


subject: UMLS:C0971122

subject_name: ICL 670A

object_name: Iron Overload


subject: UMLS:C0971122

object_name: iron poisoning


subject: UMLS:C0971122

object_name: Iron Overload, CTCAE


subject: UMLS:C0971122

object_name: hemochromatosis


subject: PUBCHEM.COMPOUND:10820564

subject_name: Fluciclovine

object_name: prostate adenocarcinoma


subject: UMLS:C4310336

subject_name: Axumin

object_name: prostate carcinoma


subject: UMLS:C4310336

object_name: prostate cancer


subject: UMLS:C4310336


subject: CHEBI:134703

subject_name: Fluciclovine (18F)


subject: UNII:LA585UM8DE

subject_name: asundexian

object_name: Hepatic impairment


subject: UNII:LA585UM8DE

object_name: acute myocardial infarction


subject: UNII:LA585UM8DE

object_name: Acute Myocardial Infarction by ECG Finding


subject: DRUGBANK:DB19088

subject_name: Asundexian


subject: DRUGBANK:DB19088


subject: DRUGBANK:DB19088


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:5281767

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:5281767

object_name: Malignant cachexia


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: Early Stage Breast Carcinoma


subject: UNII:CJN36EQM0H

object_name: HER2-Low Breast Carcinoma


subject: CHEBI:47898

subject_name: Epirubicin

object_name: invasive breast carcinoma


subject: CHEBI:47898


subject: CHEBI:64816

object_name: hormone receptor-positive breast cancer


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:4875

subject_name: Etanercept

object_name: adult acute respiratory distress syndrome


subject: CHEBI:4875

object_name: bronchiolitis obliterans syndrome


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: UMLS:C4553138

subject_name: Anti-CD20 Monoclonal Antibody

object_name: multiple sclerosis


subject: UMLS:C4553138

object_name: pregnancy related


subject: UMLS:C4553138

object_name: B cell deficiency


subject: UMLS:C4553138

object_name: Immunosuppression


subject: UMLS:C4553138

object_name: Decreased Immunologic Activity [PE]


subject: UMLS:C1328728

object_name: Neuroblastoma recurrent


subject: UNII:N7T15V1FUY

subject_name: Setmelanotide

object_name: Genetic obesity


subject: UNII:N7T15V1FUY

object_name: Thinness


subject: CHEBI:188664

subject_name: Omecamtiv Mecarbil

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: congenital amegakaryocytic thrombocytopenia 1


subject: UMLS:C0003442


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: severe congenital neutropenia


subject: UMLS:C5700219


subject: UMLS:C5700219


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: UMLS:C0003299

subject_name: Antiepileptic Agents

object_name: temporal lobe epilepsy


subject: UMLS:C0003299

object_name: Seizure Related to COVID-19


subject: UMLS:C0003299

object_name: visual epilepsy


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: opsoclonus-myoclonus syndrome


subject: UNII:4F4X42SYQ6

object_name: Opsoclonus


subject: UNII:4F4X42SYQ6

object_name: Myoclonus


subject: UNII:4F4X42SYQ6

object_name: Ataxia


subject: UNII:4F4X42SYQ6

object_name: atactic disorder


subject: UNII:4F4X42SYQ6

object_name: Ataxia as late effect of cerebrovascular disease


subject: UNII:4F4X42SYQ6

object_name: Dyssynergia


subject: UNII:4F4X42SYQ6

object_name: Ataxia, CTCAE_5


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Recurrent Childhood Glioblastoma


subject: GTOPDB:9592

object_name: Recurrent Glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:64312

subject_name: Memantine

object_name: Gambling


subject: CHEBI:90865

subject_name: Flibanserin

object_name: Childhood Breast Carcinoma


subject: CHEBI:90865

object_name: breast carcinoma


subject: CHEBI:90865

object_name: breast cancer


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: glioblastoma


subject: UMLS:C0678449

object_name: Childhood Glioblastoma


subject: UMLS:C0678449

object_name: adult glioblastoma


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: cauda equina syndrome with neurogenic bladder


subject: UNII:6GNT3Y5LMF

object_name: Neurogenic bladder


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: GTOPDB:3726

subject_name: adiponectin

object_name: gestational diabetes


subject: GTOPDB:3726

object_name: obesity due to melanocortin 4 receptor deficiency


subject: GTOPDB:3726

object_name: obesity


subject: GTOPDB:3726

object_name: Obesity, CTCAE


subject: CHEBI:81572

subject_name: Adiponectin


subject: CHEBI:81572


subject: CHEBI:81572


subject: CHEBI:81572


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: mucositis


subject: UMLS:C0034862

subject_name: Vaccines, Recombinant

object_name: Adult Penile Carcinoma


subject: UMLS:C0034862

object_name: penis carcinoma


subject: UMLS:C0034862

object_name: penile cancer


subject: UMLS:C0034862

object_name: anus cancer


subject: UMLS:C0034862

object_name: anal carcinoma


subject: PUBCHEM.COMPOUND:66811198

subject_name: SIMEPREVIR

object_name: Chronic hepatitis C genotype 4


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: UMLS:C1327826

subject_name: TransMID


subject: UMLS:C1327826


subject: UMLS:C1327826


subject: UNII:1C25MR0H0E

object_name: fibromyalgia


subject: CHEBI:134512

object_name: chronic disease


subject: CHEBI:134512

object_name: Chronic Disease


subject: CHEBI:2469

subject_name: Adefovir


subject: CHEBI:2469


subject: CHEBI:59902

subject_name: ENTECAVIR


subject: CHEBI:59902


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: obstructive sleep apnea syndrome


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UNII:F94T42GL80

object_name: osteoarthritis, knee


subject: UMLS:C4305968


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: High grade serous carcinoma


subject: CHEBI:131701

object_name: Endometrial High Grade Endometrioid Adenocarcinoma


subject: CHEBI:131701

object_name: endometrial undifferentiated carcinoma


subject: CHEBI:131701

object_name: undifferentiated carcinoma of the corpus uteri


subject: CHEBI:131701

object_name: endometrial mixed adenocarcinoma


subject: UMLS:C0597354

subject_name: Radiotracers


subject: UMLS:C0597354


subject: UMLS:C0597354


subject: UMLS:C0597354


subject: UMLS:C0597354


subject: CHEBI:49140


subject: CHEBI:49140


subject: CHEBI:49140


subject: CHEBI:49140


subject: CHEBI:49140


subject: PUBCHEM.COMPOUND:3232583


subject: PUBCHEM.COMPOUND:3232583


subject: PUBCHEM.COMPOUND:3232583


subject: PUBCHEM.COMPOUND:3232583


subject: PUBCHEM.COMPOUND:3232583


subject: PUBCHEM.COMPOUND:451195

subject_name: Fluorodeoxyglucose F 18


subject: PUBCHEM.COMPOUND:451195


subject: PUBCHEM.COMPOUND:451195


subject: PUBCHEM.COMPOUND:451195


subject: PUBCHEM.COMPOUND:451195


subject: CHEBI:49134


subject: CHEBI:49134


subject: CHEBI:49134


subject: CHEBI:49134


subject: CHEBI:49134


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: GTOPDB:12212

subject_name: efmarodocokin alfa

object_name: acute graft versus host disease


subject: UNII:NYZ11835VX

subject_name: EFMARODOCOKIN ALFA


subject: UMLS:C5417921


subject: DRUGBANK:DB18006

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297789

object_name: lymphoma, non-Hodgkin, familial


subject: CHEMBL.COMPOUND:CHEMBL4297789

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297789

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297789

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4053580

subject_name: Anti-CD20-engineered Toxin Body MT-3724


subject: UMLS:C4053580


subject: UMLS:C4053580


subject: UMLS:C4053580


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: habitual spontaneous abortion


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: frenulum; hypertrophy, lip


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UMLS:C2987380

subject_name: Mucoadhesive Oral Wound Rinse

object_name: Breast cancer recurrent


subject: UMLS:C2987380

object_name: progesterone-receptor positive breast cancer


subject: UMLS:C2987380

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C2987380

object_name: Her2-receptor negative breast cancer


subject: UMLS:C2987380

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C2987380

object_name: Carcinoma breast stage IV


subject: UMLS:C2987380

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2987380

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2987380

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C2987380

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2987380

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2987380

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C2987380

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C2987380

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2987380

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2987380

object_name: Oral Complication


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: cholangiocarcinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine


subject: UNII:94AC8YWE3I

subject_name: ULTEVURSEN

object_name: retinitis pigmentosa


subject: UNII:94AC8YWE3I

object_name: retinitis pigmentosa 1


subject: UNII:94AC8YWE3I

object_name: eye disorder


subject: UNII:94AC8YWE3I

object_name: Eye Diseases, Hereditary


subject: UNII:94AC8YWE3I

object_name: retinal disease


subject: UNII:94AC8YWE3I

object_name: Usher syndrome type 2


subject: UNII:94AC8YWE3I

object_name: vision disorder


subject: UNII:94AC8YWE3I

object_name: Total visual and total hearing impairment


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: acute myocardial infarction


subject: CHEBI:39548

object_name: Acute Myocardial Infarction by ECG Finding


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:63624

subject_name: Telbivudine

object_name: hepatitis A


subject: CHEBI:63624

object_name: hepatitis


subject: CHEBI:92076

subject_name: AFIMOXIFENE

object_name: Childhood Breast Carcinoma


subject: CHEBI:92076

object_name: breast cancer


subject: CHEBI:231618


subject: CHEBI:231618


subject: CHEMBL.COMPOUND:CHEMBL2109553

object_name: metastatic prostate carcinoma


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Adverse drug response


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:60654

subject_name: valproate

object_name: glioblastoma


subject: CHEBI:60654

object_name: Childhood Glioblastoma


subject: CHEBI:60654

object_name: adult glioblastoma


subject: UNII:WZ9TJ0L9Y8

subject_name: Tinengotinib

object_name: prostate carcinoma


subject: UNII:WZ9TJ0L9Y8

object_name: prostate cancer


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:8228

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Prevention problem


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Staphylococcal bacteraemia


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C4725113

object_name: cervical intraepithelial neoplasia


subject: UMLS:C4725113

object_name: dysplasia of cervix


subject: UMLS:C4725113

object_name: uterine cervix carcinoma in situ


subject: CHEBI:60799

subject_name: Esketamine

object_name: Hepatic impairment


subject: UNII:4Z4DFR9BX7

object_name: gingivitis


subject: UMLS:C5139735


subject: CHEBI:28315

subject_name: Oxypurinol

object_name: heart failure


subject: CHEBI:28315

object_name: congestive heart failure


subject: CHEBI:64911

subject_name: antimitotic

object_name: Advanced cancer


subject: UMLS:C0003379

subject_name: Antimitotic Agents


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Avitaminosis


subject: CHEBI:135239

subject_name: Indobufen

object_name: Heartburn


subject: CHEBI:135239

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C5964811

object_name: graft versus host disease


subject: UMLS:C4019381

subject_name: Granulocyte component of blood

object_name: childhood malignant neoplasm


subject: UMLS:C5399232

subject_name: belantamab

object_name: plasma cell myeloma


subject: CHEBI:135942

subject_name: Laropiprant

object_name: rosacea


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: CHEBI:82339

subject_name: Merphalan

object_name: mucositis


subject: CHEBI:28876

subject_name: Melphalan


subject: UNII:C857R7G2U6

subject_name: SODIUM PENTABORATE PENTAHYDRATE

object_name: Overweight and obesity


subject: UMLS:C5848978

subject_name: Sodium Pentaborate Pentahydrate


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:95165

object_name: Childhood Breast Carcinoma


subject: CHEBI:95165

object_name: breast carcinoma


subject: CHEBI:95165

object_name: breast cancer


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:D07V79Q44T

object_name: breast neoplasm


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY

object_name: autoimmune thrombocytopenia


subject: CHEBI:143658

object_name: primitive neuroectodermal tumor


subject: CHEBI:143658

object_name: neuroepithelioma


subject: CHEBI:143658

object_name: peripheral primitive neuroectodermal tumor


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: UMLS:C0699319

subject_name: Cytoxan


subject: UMLS:C0699319


subject: UMLS:C0699319

object_name: Ewing sarcoma


subject: UMLS:C0699319

object_name: malignant soft tissue neoplasm


subject: UMLS:C0699319

object_name: sarcoma


subject: UMLS:C0699319


subject: UMLS:C0699319

object_name: pediatric osteosarcoma


subject: UMLS:C0699319

object_name: Osteosarcoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:16199

subject_name: Urea


subject: CHEBI:16199


subject: CHEBI:16199


subject: CHEBI:16199

object_name: Drug toxicity


subject: CHEBI:16199

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C5782829

subject_name: ROPivacaine 0.2% injectable solution

object_name: rheumatism knee (non-specific)


subject: UMLS:C5782829

object_name: Disorder of knee


subject: CHEBI:8378

subject_name: Prednisolone

object_name: childhood onset asthma


subject: UMLS:C2986994

object_name: Plexosarcoma


subject: UMLS:C2986994

object_name: paraganglioma


subject: UMLS:C2986994

object_name: adrenal gland pheochromocytoma


subject: UMLS:C2986994

object_name: pheochromocytoma


subject: UMLS:C2986994

object_name: renal cell carcinoma


subject: UMLS:C2986994

object_name: kidney neoplasm


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine


subject: PUBCHEM.COMPOUND:136924190


subject: PUBCHEM.COMPOUND:136924190


subject: PUBCHEM.COMPOUND:136924190


subject: PUBCHEM.COMPOUND:136924190


subject: UMLS:C0962969

subject_name: RAD 001

object_name: cervical cancer


subject: UMLS:C0962969

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:161680

subject_name: Aztreonam

object_name: chronic kidney disease


subject: CHEBI:161680

object_name: Chronic uremia


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: PUBCHEM.COMPOUND:3379

subject_name: Nasalide

object_name: asthma


subject: UMLS:C1569761

subject_name: flunisolide HFA


subject: CHEBI:5106

subject_name: Flunisolide


subject: UMLS:C5557402

subject_name: Engineered Toxin Body Targeting PD-L1 MT-6402

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5557402

object_name: non-small cell lung carcinoma


subject: UMLS:C5557402

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1688539

object_name: intellectual disability


subject: UMLS:C1688539

object_name: cerebral palsy


subject: UMLS:C1688539

object_name: traumatic encephalopathy


subject: UMLS:C1688539

object_name: traumatic brain injury


subject: UMLS:C1688539

object_name: stroke disorder


subject: UMLS:C1688539

object_name: cerebrovascular disorder


subject: UMLS:C1688539

object_name: Stroke (heart beat)


subject: UMLS:C1688539

object_name: Stroke, CTCAE


subject: PUBCHEM.COMPOUND:19609831

subject_name: Rebimastat

object_name: hormone-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:19609831

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:2611

subject_name: Alprazolam

object_name: reported history of cataract surgery


subject: CHEBI:2611

object_name: Sedation


subject: CHEBI:2611

object_name: Sedated


subject: CHEBI:48814

subject_name: Chloral

object_name: Sleep Deprivation


subject: CHEBI:5818

subject_name: Hydroxyzine


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:1CIV2UMO40

subject_name: Minnelide

object_name: pancreatic adenosquamous carcinoma


subject: CHEBI:174615

object_name: myeloid neoplasm


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:201431

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:9570

subject_name: Thiotepa


subject: UMLS:C0020677

subject_name: Hypotonic Solutions

object_name: Hypernatremia


subject: UMLS:C0020677

object_name: Hypernatremia, CTCAE


subject: CHEBI:141217

object_name: endogenous depression


subject: CHEBI:141217

object_name: major depressive disorder


subject: CHEBI:141217

object_name: Depressed mood


subject: CHEBI:141217

object_name: Cancer patients and suicide and depression


subject: CHEBI:141217

object_name: Depressed - symptom


subject: CHEBI:141217

object_name: Depression, CTCAE


subject: CHEBI:28969

subject_name: Dimethyltryptamine


subject: CHEBI:28969


subject: CHEBI:28969


subject: CHEBI:28969


subject: CHEBI:28969


subject: CHEBI:28969


subject: UMLS:C4053606

subject_name: Ivuxolimab

object_name: neoplasm


subject: UMLS:C3529795


subject: UMLS:C0534628

subject_name: Endostatins

object_name: neoplastic meningitis


subject: UMLS:C1705207

subject_name: Endostar


subject: CHEBI:23965

subject_name: estradiol

object_name: Metastatic Breast Carcinoma


subject: CHEBI:23965

object_name: Estrogen Receptor-Positive Breast Carcinoma


subject: UMLS:C0701187

subject_name: Campto

object_name: colorectal cancer


subject: UMLS:C0701187

object_name: colorectal carcinoma


subject: UMLS:C0701187

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:94366

subject_name: itraconazole

object_name: Uses contraception (finding)


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: CHEBI:135948

subject_name: Amifampridine

object_name: myasthenia gravis


subject: CHEBI:135948

object_name: Myasthenia Gravis, CTCAE


subject: UMLS:C1704464

subject_name: nitrogenous base


subject: UMLS:C1704464


subject: CHEBI:18282

subject_name: nucleobase


subject: CHEBI:18282


subject: KEGG.COMPOUND:C00701

subject_name: Base


subject: KEGG.COMPOUND:C00701


subject: PR:000009685

subject_name: putative BPIFA4P protein


subject: PR:000009685


subject: UniProtKB:Q86YQ2

subject_name: LATH_HUMAN Putative BPIFA4P protein (sprot)


subject: UniProtKB:Q86YQ2


subject: CHEBI:8665

subject_name: Pyridostigmine


subject: CHEBI:8665


subject: CHEBI:133616

subject_name: Val-Gly

object_name: skin melanoma


subject: UMLS:C5202954

subject_name: V-Series Nerve Agent VG


subject: CHEBI:81784

subject_name: triflumizole

object_name: ovarian carcinoma


subject: CHEBI:81784

object_name: malignant epithelial tumor of ovary


subject: UMLS:C3274540

subject_name: Procure


subject: UMLS:C3274540


subject: UMLS:C0005515

subject_name: Biological Factors

object_name: psoriasis


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: Gastroenteritis norovirus


subject: PUBCHEM.COMPOUND:57656761

object_name: Nerve Pain


subject: CHEMBL.COMPOUND:CHEMBL3545221


subject: CHEBI:3766

subject_name: Clozapine

object_name: adult lymphoma


subject: CHEBI:3766

object_name: lymphoma


subject: CHEBI:3766

object_name: pediatric lymphoma


subject: CHEBI:3766

object_name: leukemia


subject: CHEBI:3766

object_name: childhood leukemia


subject: UNII:D652ZWF066

subject_name: sodium zirconium cyclosilicate

object_name: type 2 diabetes mellitus


subject: UMLS:C5907987

subject_name: BTK Inhibitor LP-168

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5907987

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C5907987

object_name: mantle cell lymphoma


subject: UMLS:C5907987

object_name: hairy cell leukemia


subject: UMLS:C5907987

object_name: marginal zone lymphoma


subject: UMLS:C5907987

object_name: MALT lymphoma


subject: UMLS:C5907987

object_name: follicular lymphoma


subject: UMLS:C5907987

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UMLS:C5907987

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:31348

subject_name: Capecitabine

object_name: disease free survival


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: CHEBI:93786


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: skin atrophy


subject: PUBCHEM.COMPOUND:134506

object_name: Skin Atrophy, CTCAE 5.0


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:85252


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:40021

subject_name: Tiratricol


subject: CHEBI:40021


subject: PUBCHEM.COMPOUND:198621


subject: PUBCHEM.COMPOUND:198621


subject: UMLS:C0146607

subject_name: Triac Cold


subject: UMLS:C0146607


subject: PUBCHEM.COMPOUND:131729795

subject_name: Carboplatin Paclitaxel

object_name: head and neck cancer


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Drug Resistant Epilepsy


subject: CHEBI:7421

subject_name: NAC


subject: UMLS:C0935953

subject_name: Mobist

object_name: leukemia


subject: UMLS:C0935953

object_name: childhood leukemia


subject: UMLS:C2826358

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C2826358

object_name: stage IV pancreatic cancer


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: aortic stenosis


subject: CHEBI:83766

subject_name: Olaparib

object_name: Advanced Gastric Adenocarcinoma


subject: CHEBI:8081

subject_name: Phentolamine

object_name: severe pre-eclampsia


subject: CHEBI:28939

object_name: traumatic brain injury


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: migraine


subject: UMLS:C3540792

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C2001417

object_name: metastatic melanoma


subject: UMLS:C2001417

object_name: metastatic prostate carcinoma


subject: UMLS:C2001417

object_name: Carcinoma breast stage IV


subject: UMLS:C2001417

object_name: glioblastoma


subject: UMLS:C2001417

object_name: Brain Stem Glioblastoma


subject: UMLS:C2001417

object_name: glioma susceptibility 1


subject: UMLS:C2001417

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C2001417

object_name: Recurrent Glioblastoma


subject: UMLS:C2001417

object_name: prostate carcinoma


subject: UMLS:C2001417

object_name: prostate cancer


subject: UMLS:C2001417

object_name: Melanoma recurrent


subject: UMLS:C2001417

object_name: Childhood Breast Carcinoma


subject: UMLS:C2001417

object_name: breast carcinoma


subject: UMLS:C2001417

object_name: breast cancer


subject: UMLS:C2001417

object_name: brain cancer


subject: UMLS:C2001417

object_name: brain neoplasm


subject: UMLS:C2001417

object_name: Childhood Glioblastoma


subject: UMLS:C2001417

object_name: adult glioblastoma


subject: UMLS:C5782830

subject_name: ROPivacaine 0.5% injectable solution

object_name: pharyngitis


subject: UMLS:C5782830

object_name: Pharyngitis, CTCAE


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Stage IVB Oral Cavity Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Stage IVC Oral Cavity Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Stage IVA Oral Cavity Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:63791

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:63791

object_name: Recurrent Rectal Cancer


subject: CHEBI:63791

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791

object_name: Recurrent Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:63791

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:63791

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:63791

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:63791

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:63791

object_name: Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:63791

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:63791

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:63791

object_name: Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:63791

object_name: Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:63791

object_name: Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:63791

object_name: Colon cancer recurrent


subject: CHEBI:63791

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:63791

object_name: Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma


subject: CHEBI:63791

object_name: Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:63791

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:63791

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: salivary gland squamous cell carcinoma


subject: CHEBI:63791

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:63791

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:63791

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:63791

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:63791

object_name: tongue cancer


subject: CHEBI:63791

object_name: tongue carcinoma


subject: UMLS:C5667035

subject_name: CDK9 Inhibitor PRT2527

object_name: hormone receptor-positive breast cancer


subject: UMLS:C5667035

object_name: non-small cell lung carcinoma


subject: UMLS:C5667035

object_name: malignant soft tissue neoplasm


subject: UMLS:C5667035

object_name: sarcoma


subject: CHEMBL.COMPOUND:CHEMBL3707293

object_name: type 2 diabetes mellitus


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Stage II Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage II Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage III Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage I Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage I Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7


subject: UNII:XD423NK2WO

subject_name: flotufolastat f-18 gallium

object_name: prostate carcinoma


subject: UMLS:C5783385

subject_name: flotufolastat F 18 gallium


subject: CHEBI:156295

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:156295

object_name: metabolic syndrome X


subject: CHEBI:156295

object_name: Heart Disease Risk Factors


subject: CHEBI:156295

object_name: Abdominal obesity


subject: UMLS:C3643658

subject_name: atorvastatin / ezetimibe

object_name: ST-elevation myocardial infarction


subject: UMLS:C3643658

object_name: ST Elevation Myocardial Infarction


subject: UMLS:C3643658

object_name: Non-ST Elevated Myocardial Infarction


subject: UMLS:C3643658

object_name: Non-ST Elevation Myocardial Infarction


subject: UMLS:C3643658


subject: CHEBI:35476

subject_name: antipsychotic agent

object_name: psychosis


subject: UMLS:C0040615

subject_name: Antipsychotic Agents


subject: CHEBI:135919

subject_name: Nesiritide

object_name: hyperinsulinism


subject: CHEBI:135919

object_name: Hyperinsulinemia


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Carcinoma liver resectable


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: Blood Pressure Finding


subject: UMLS:C1550678

object_name: Systemic arterial pressure


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: liver carcinoma


subject: CHEBI:8382

subject_name: Prednisone

object_name: Childhood Breast Carcinoma


subject: CHEBI:8382

object_name: breast carcinoma


subject: CHEBI:8382

object_name: breast cancer


subject: MESH:D019444

subject_name: Vaccines, DNA

object_name: High Grade Cervical Intraepithelial Neoplasia


subject: UNII:T5IRO3534A

subject_name: Oncovin

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:45716

subject_name: Vorinostat

object_name: paraganglioma


subject: CHEBI:45716

object_name: adrenal gland pheochromocytoma


subject: CHEBI:45716

object_name: pheochromocytoma


subject: CHEBI:9150

subject_name: Simvastatin

object_name: carotid artery disorder


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: Adenocarcinoma of the prostate stage II


subject: UNII:9AG41L3AOQ

object_name: Adenocarcinoma of the prostate stage III


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Multiple Trauma


subject: CHEBI:18357

subject_name: Norepinephrine


subject: UMLS:C2346815

object_name: non-small cell lung carcinoma


subject: PR:000009060

subject_name: insulin-like peptide INSL5

object_name: pericardial tuberculosis


subject: PR:000009060

object_name: Human immunodeficiency virus (HIV) status


subject: PR:000013980

subject_name: Rho-related GTP-binding protein RhoF


subject: PR:000013980


subject: PR:000023845

subject_name: DNA-directed RNA polymerase subunit beta


subject: PR:000023845


subject: UniProtKB:P0A8V2

subject_name: RPOB_ECOLI DNA-directed RNA polymerase subunit beta (sprot)


subject: UniProtKB:P0A8V2


subject: UMLS:C3890420

subject_name: Realgar-Indigo naturalis Formulation


subject: UMLS:C3890420


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Prilocaine adverse reaction


subject: CHEBI:50885

subject_name: Fludrocortisone

object_name: Mechanical ventilation pressure high


subject: CHEBI:50885

object_name: respiratory failure


subject: CHEBI:50885

object_name: bronchopulmonary dysplasia


subject: CHEBI:50885

object_name: Respiratory insufficiency


subject: CHEBI:50885

object_name: Extracorporeal membrane oxygenation complication


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: neuronal intestinal dysplasia


subject: PUBCHEM.COMPOUND:46783403

object_name: chronic intestinal pseudoobstruction


subject: UMLS:C0771180

subject_name: dextrose 15 % in water

object_name: Myofascial Trigger Point Pain


subject: UMLS:C0770268

subject_name: dextrose 1.5 % in water


subject: UMLS:C0770259

subject_name: Dextrose 5% and Water


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: progesterone receptor-negative breast cancer


subject: UNII:DPT0O3T46P

object_name: estrogen receptor-negative breast cancer


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: PUBCHEM.COMPOUND:156963654


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: CHEBI:187893

subject_name: Baclofen

object_name: hepatitis C


subject: UMLS:C0054950

subject_name: Antigens, CD30

object_name: enteropathy-associated T-cell lymphoma


subject: UMLS:C0054950

object_name: Lymphoma, Extranodal NK-T-Cell


subject: UMLS:C0054950

object_name: diffuse large B-cell lymphoma


subject: UMLS:C0054950

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C0054950

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C0054950

object_name: anaplastic large cell lymphoma


subject: PR:000001964

subject_name: tumor necrosis factor receptor superfamily member 8


subject: PR:000001964


subject: PR:000001964


subject: PR:000001964


subject: PR:000001964


subject: PR:000001964


subject: UMLS:C4039583

subject_name: Chimeric antigen receptor


subject: UMLS:C4039583


subject: UMLS:C4039583


subject: UMLS:C4039583


subject: UMLS:C4039583


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: cerebral palsy


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C4688302

subject_name: Hormone Therapy Agent

object_name: Non-obstructive azoospermia


subject: UMLS:C4688302

object_name: male infertility


subject: UMLS:C4688302

object_name: inability to impregnate


subject: UMLS:C4688302

object_name: hypogonadism, male


subject: UMLS:C4688302

object_name: hormone deficiency


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: nasopharyngeal carcinoma


subject: CHEBI:168243

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:91327

subject_name: Tivozanib

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:91327

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:91327

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:59213

subject_name: Cefpiramide

object_name: osteoarthritis


subject: CHEBI:195334


subject: CHEBI:4027


subject: UMLS:C4508892

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam


subject: PUBCHEM.COMPOUND:9824461

object_name: acute respiratory failure


subject: PUBCHEM.COMPOUND:9824461

object_name: Physical trauma


subject: PUBCHEM.COMPOUND:9824461

object_name: Injury


subject: PUBCHEM.COMPOUND:9824461

object_name: Trauma


subject: PUBCHEM.COMPOUND:9824461

object_name: stroke disorder


subject: PUBCHEM.COMPOUND:9824461

object_name: Stroke (heart beat)


subject: PUBCHEM.COMPOUND:9824461

object_name: Stroke, CTCAE


subject: PUBCHEM.COMPOUND:9824461

object_name: Sepsis


subject: PUBCHEM.COMPOUND:9824461

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:9824461

object_name: Shock


subject: PR:000015813

subject_name: succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial

object_name: glioblastoma


subject: PR:000015813

object_name: Childhood Glioblastoma


subject: PR:000015813

object_name: adult glioblastoma


subject: CHEBI:64312

subject_name: Memantine

object_name: non-verbal learning disability


subject: CHEBI:167638

subject_name: Labetalol

object_name: nicotine dependence


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: cytokine release syndrome


subject: UNII:19J3781LPM

object_name: Cytokine Release Syndrome, CTCAE


subject: UMLS:C5383409

subject_name: daratumumab / hyaluronidase

object_name: plasma cell myeloma


subject: UMLS:C5226733

object_name: allergic asthma


subject: CHEBI:35627

subject_name: beta-lactam

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: long COVID-19


subject: UMLS:C1527137

object_name: Chronic post-COVID-19 syndrome


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:192601

object_name: Alzheimer disease


subject: UNII:F40IRN5981

subject_name: Chiauranib

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5203431

subject_name: Gemcitabine Liquid Injection


subject: UMLS:C3282888

object_name: atopic conjunctivitis


subject: UMLS:C2828366

subject_name: Extract (substance)

object_name: Overweight and obesity


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: adult acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: childhood acute myeloid leukemia


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: cocaine use disorder


subject: CHEBI:28939

object_name: opiate dependence


subject: CHEBI:28939

object_name: Stimulant use disorder


subject: CHEBI:5959

subject_name: Irbesartan

object_name: echocardiography: left atrial volume


subject: CHEBI:5959

object_name: Poisoning by, adverse effect of and underdosing of other antihypertensive drugs


subject: CHEBI:5959

object_name: hypertensive heart disease


subject: CHEBI:8774

subject_name: Ramipril


subject: CHEBI:8774


subject: CHEBI:8774


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: non-small cell lung carcinoma


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: carpal tunnel syndrome 1


subject: CHEBI:2666

object_name: carpal tunnel syndrome


subject: CHEBI:2666

object_name: Cumulative Trauma Disorders


subject: UNII:1351PE5UGS

subject_name: Elotuzumab

object_name: immunoglobulin G4-related sclerosing disease


subject: UNII:1351PE5UGS

object_name: Immunoglobulin G4-Related Disease


subject: CHEBI:233417

subject_name: Omilancor

object_name: ulcerative colitis


subject: CHEBI:233417

object_name: inflammatory bowel disease 1


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: delirium


subject: UMLS:C3714501

object_name: Delirium, CTCAE


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:4672

subject_name: Docetaxel

object_name: tumor suppressor gene on chromosome 11


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: Locally advanced prostate cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UMLS:C0678115

subject_name: Uromitexan

object_name: metastatic colorectal cancer


subject: UMLS:C0678115

object_name: metastatic prostate carcinoma


subject: UMLS:C0678115


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:36939

subject_name: Fluorine F-18

object_name: alcohol abuse


subject: CHEBI:36939

object_name: alcohol dependence


subject: UMLS:C0758290

subject_name: IRX 2

object_name: Childhood Breast Carcinoma


subject: UMLS:C0758290

object_name: breast carcinoma


subject: UMLS:C0758290

object_name: breast cancer


subject: UMLS:C0758290

object_name: breast neoplasm


subject: UNII:YK5DTP8NHU

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C2830064


subject: PUBCHEM.COMPOUND:3222

object_name: preeclampsia postpartum


subject: PUBCHEM.COMPOUND:3222

object_name: Maternal hypertension


subject: PUBCHEM.COMPOUND:3222

object_name: severe pre-eclampsia


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4784


subject: UMLS:C0939403

subject_name: NIFEdipine ER

object_name: preeclampsia


subject: UMLS:C0939403


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: peritonitis


subject: CHEBI:177770

subject_name: Ganetespib

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:177770

object_name: Squamous cell carcinoma of the oral cavity stage I


subject: CHEBI:177770

object_name: Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:177770

object_name: Squamous cell carcinoma of the oral cavity stage II


subject: CHEBI:177770

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: CHEBI:177770

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:177770

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:177770

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:177770

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: CHEBI:177770

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:177770

object_name: Hypopharyngeal squamous cell carcinoma stage I


subject: CHEBI:177770

object_name: Hypopharyngeal squamous cell carcinoma stage II


subject: CHEBI:177770

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:177770

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:177770

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:177770

object_name: Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: strabismus


subject: UNII:YZS3R7LP44

object_name: strabismus on exam (physical finding)


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage II Lung Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIA Lung Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IIB Lung Cancer AJCC v8


subject: CHEBI:231679

object_name: EGFR gene mutation


subject: CHEBI:231679

object_name: ALK Gene Rearrangement


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: metabolic disease


subject: UMLS:C1527137

object_name: Glucose metabolism disorders (incl diabetes mellitus)


subject: UMLS:C1527137

object_name: Insulin Sensitivity


subject: UMLS:C1527137

object_name: Blood Pressure Finding


subject: UMLS:C1527137

object_name: Systemic arterial pressure


subject: UMLS:C1527137

object_name: Inflammation


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE

object_name: aortic stenosis


subject: CHEBI:6904

subject_name: Metoprolol


subject: UNII:FN12T66RMN

subject_name: EFPREZIMOD ALFA

object_name: graft versus host disease


subject: UNII:FN12T66RMN

object_name: leukemia


subject: UNII:FN12T66RMN

object_name: childhood leukemia


subject: UMLS:C4287663


subject: UMLS:C4287663


subject: UMLS:C4287663


subject: CHEBI:50733

subject_name: nutraceutical

object_name: colorectal cancer


subject: CHEBI:50733

object_name: colorectal carcinoma


subject: CHEBI:50733

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:93775

subject_name: Amethopterin

object_name: chronic childhood arthritis


subject: CHEBI:93775

object_name: juvenile chronic polyarthritis


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Malignant neoplasm of female breast


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: GTOPDB:11827

subject_name: telitacicept

object_name: neuromuscular disease


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: UMLS:C5238006


subject: CHEBI:24433

subject_name: group

object_name: myasthenia gravis


subject: CHEBI:24433

object_name: Myasthenia Gravis, CTCAE


subject: CHEBI:24433

object_name: Autoimmunity


subject: CHEBI:24433


subject: GTOPDB:2495

subject_name: insulin-like growth factor 1

object_name: Burn due to and following ultraviolet B phototherapy


subject: CHEBI:80343

subject_name: Mecasermin


subject: UMLS:C0021665

subject_name: Insulin-Like Growth Factor I


subject: PR:000009182


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: B cell deficiency


subject: MESH:D000086663

object_name: Autoimmune blistering disease


subject: MESH:D000086663

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:1972

subject_name: Fungizone

object_name: Cryptococcal meningitis


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: substance abuse


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Hypercholesterolemia


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C1721308

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:5276854

subject_name: Epicept NP-1

object_name: Diabetic peripheral neuropathy


subject: PUBCHEM.COMPOUND:5276854

object_name: neuralgia


subject: PUBCHEM.COMPOUND:5276854

object_name: Neuralgia, CTCAE


subject: UMLS:C4305970


subject: UMLS:C4305970


subject: UMLS:C4305970


subject: UMLS:C4764260

subject_name: PI3K-delta Inhibitor YY-20394

object_name: follicular lymphoma


subject: CHEBI:3647

subject_name: Chlorpromazine

object_name: MGMT-Unmethylated Glioblastoma


subject: UMLS:C2698134

subject_name: demcizumab

object_name: Solid Neoplasm


subject: CHEBI:135935

subject_name: Tapentadol

object_name: Prolonged QTc Interval, CTCAE


subject: CHEBI:135935

object_name: Prolonged QTc interval


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Autoimmunity


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: knee pain chronic


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: SYSTEMIC INFLAMMATORY PROCESS


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: osteoarthritis


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: CHEBI:89324

object_name: rheumatoid arthritis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C2608294

subject_name: Nasal Spray brand of phenylephrine

object_name: Dry Eye, CTCAE


subject: UMLS:C2608294

object_name: Dryness of eye


subject: DRUGBANK:DB18172

object_name: acute myeloid leukemia by FAB classification


subject: DRUGBANK:DB18172

object_name: acute myeloid leukemia


subject: UMLS:C5238470

subject_name: Pegylated SN-38 Conjugate PLX038

object_name: Childhood Solid Neoplasm


subject: UMLS:C5238470

object_name: Adult Solid Neoplasm


subject: UMLS:C5238470


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Alzheimer disease type 1


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: pregnancy related


subject: UNII:XX2MN88N5D

subject_name: Efalizumab

object_name: graft versus host disease


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C1571394

object_name: plasma cell myeloma


subject: CHEBI:94187

subject_name: Givinostat


subject: UMLS:C3273936

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C3273936


subject: UMLS:C3273936


subject: UMLS:C3273936

object_name: Solid Neoplasm


subject: UMLS:C0812733

subject_name: Injection, eptifibatide, 5 mg administered

object_name: Acute Ischemic Stroke


subject: UMLS:C0812733

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: HER2 positive


subject: UMLS:C5544403

subject_name: Secretome


subject: CHEBI:2704

subject_name: Anastrozole

object_name: morbid obesity


subject: CHEBI:2704

object_name: Class 3 Obesity


subject: PUBCHEM.COMPOUND:75038

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:75038

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2


subject: PUBCHEM.COMPOUND:4056


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: UNII:71ANL51TLA


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: CHEBI:28869


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: UNII:12V8PA4WCH


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEBI:16374


subject: CHEBI:145592

object_name: Inflammation


subject: CHEBI:61025

subject_name: Chondroitin


subject: CHEBI:16137


subject: CHEBI:77590

subject_name: Armodafinil

object_name: sarcoidosis


subject: CHEBI:77590

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:77590

object_name: Somnolence


subject: CHEBI:77590

object_name: Drowsiness


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859


subject: UMLS:C5203352

subject_name: Carboplatin Liquid Injection

object_name: Small cell lung cancer extensive stage


subject: UMLS:C0499106

subject_name: Injection, carboplatin, 50 mg


subject: CHEBI:3441

subject_name: Carvedilol

object_name: glioblastoma


subject: CHEBI:3441

object_name: Childhood Glioblastoma


subject: CHEBI:3441

object_name: adult glioblastoma


subject: CHEBI:3441

object_name: Brain Stem Glioblastoma


subject: CHEBI:3441

object_name: glioma susceptibility 1


subject: UMLS:C4087034

subject_name: Spleen Tyrosine Kinase Inhibitor HMPL-523

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4087034

object_name: acute myeloid leukemia


subject: CHEBI:52717

subject_name: Bortezomib

object_name: smoldering plasma cell myeloma


subject: CHEBI:52717

object_name: Plasmacytosis


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan